[SYRE] YoY Annual Result on 31-Dec-2015 [#FY]

Stock
[SYRE] Spyre Therapeutics, Inc.
Announcement Date
31-Dec-2015
Financial Year
2015
Quarter
31-Dec-2015 [#FY]
Profit Trend
YoY- -9.16%
Quarter Report
SYRE's Result
SYRE's Financial Summary
View:
Show?
Annual Result
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Revenue 0 0 3,888 5,205 4,628 6,085 0 -
PBT -80,893 -78,254 -44,348 -27,236 -21,698 -11,295 -10,347 40.83%
Tax -593 0 0 0 0 0 0 -
NP -80,893 -78,254 -44,348 -27,236 -21,698 -11,295 -10,347 40.83%
Tax Rate - - - - - - - -
Total Cost 80,893 78,254 48,236 32,441 26,326 17,380 10,347 40.83%
Ratio Analysis
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
NP Margin 0.00 0.00 -1,140.64 -523.27 -468.84 -185.62 0.00 -
Per Share
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
EPS -37.89 -61.23 -53.25 -45.01 -55.40 -25.20 -18.91 12.26%
EPS Diluted -37.89 -61.23 -53.25 -45.01 -55.40 -25.20 -18.91 12.26%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.